Monica M Bertagnolli

9PUBLICATIONS
34CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied theatre
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 16, 2024
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.

Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon

|Apr 17, 2023
Achieving the Goals of the Cancer Moonshot Requires Progress against All Cancers.

Monica M Bertagnolli, Danielle Carnival, Elizabeth M Jaffee

|Apr 25, 2022
Linking Genotype to Phenotype: Bench to Bedside.

Suzanne George, Monica M Bertagnolli

|Feb 17, 2022
Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.

Federico Innocenti, Akram Yazdani, Naim Rashid

|Dec 01, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Ethan Basch, Claus Becker, Lauren J Rogak

|Sep 24, 2020
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.

Monica M Bertagnolli, Charles D Blanke, Walter J Curran

Pageof 2

Frequent Collaborators

3 joint publications

Alan P Venook

2 joint publications

Fang-Shu Ou

2 joint publications

Heinz-Josef Lenz

1 joint publications

Alexander B Sibley